Mesh Bio: The role of deep tech in modern healthcare
What if we can prevent catastrophic diseases such as diabetes, kidney failure, and stroke with deep tech? The word deep tech might still be unfamiliar to people’s ears as it first emerged in 2014.
Investing in healthtech to tackle Indonesia’s greatest challenges
The COVID-19 pandemic has exposed critical gaps in Indonesia’s healthcare infrastructure, revealing structural and systemic shortcomings that will require scalable solutions. Change doesn't happen overnight, particularly for the healthcare sector, which consists of multiple intertwined industries with strict regulatory oversight. But precisely because the industry is highly regulated, regulations play a huge role in shaping trends.
Moosa Genetics, an animal genomics and biotechnology startup, announced a new funding led by East Ventures
Moosa Genetics, an animal genomics and biotechnology startup based in Indonesia, announced that the company raised funding led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia, with the participation from angel investors. This funding will be allocated to build laboratory, team, marketing, and wagyu partnership to fulfill the demand for its customers.
Biotechnology and the future of healthcare in Indonesia
Indonesia generates millions of tonnes of waste daily, making it one of the largest waste-producing countries globally. The country also has the highest municipal waste in Southeast Asia, creating a pressing problem that affects public health, the environment, and the economy. But amidst this crisis lies an opportunity. Entrepreneurs and innovators can create sustainable solutions that can transform waste management practices in Indonesia.